The Minister of Health Dr Aaron Motsoaledi will this week launch two critical cancer policies namely, Cervical and Breast Cancer policies aimed at addressing high mortality caused by these cancers, management of the condition as well as improve the quality of life of women in South Africa.
Breast and Cervical cancers have been identified amongst the leading cause of deaths among South African women, especially women aged 30 years and older.
While the Cervical cancer prevention and control policy will assist to prevent the disease by promoting healthy lifestyle and provide Human papillomavirus (HPV) vaccination, the Breast cancer control policy will focus on breast cancer awareness, early detection, treatment and care. The implementation of both policies will provide clinical support for women, who are both at risk of developing the disease later in life and currently undergoing treatment to survive and live healthy lives.
The Department of Health is working on a 10-year plan to equip hospitals with the necessary facilities to care and support patients with cancer in an effort to address the Hospital Service Equity and accessibility for women.
The Cervical Cancer prevention and control Policy will enable the introduction of new screening technique called liquid-based cytology which is an improvement from papsmear technique and is more comfortable and produce reliable results.
The Breast cancer control policy will allow women who are diagnosed early to have access to treatment such as Trutusumab which will prolong life if treatment is completed and minimise the recurrence of the disease women.
End
South African National Department of Health
The Minister of Health Dr Aaron Motsoaledi will this week launch two critical cancer policies namely, Cervical and Breast Cancer policies aimed at addressing high mortality caused by these cancers, management of the condition as well as improve the quality of life of women in South Africa.
Breast and Cervical cancers have been identified amongst the leading cause of deaths among South African women, especially women aged 30 years and older.
While the Cervical cancer prevention and control policy will assist to prevent the disease by promoting healthy lifestyle and provide Human papillomavirus (HPV) vaccination, the Breast cancer control policy will focus on breast cancer awareness, early detection, treatment and care. The implementation of both policies will provide clinical support for women, who are both at risk of developing the disease later in life and currently undergoing treatment to survive and live healthy lives.
The Department of Health is working on a 10-year plan to equip hospitals with the necessary facilities to care and support patients with cancer in an effort to address the Hospital Service Equity and accessibility for women.
The Cervical Cancer prevention and control Policy will enable the introduction of new screening technique called liquid-based cytology which is an improvement from papsmear technique and is more comfortable and produce reliable results.
The Breast cancer control policy will allow women who are diagnosed early to have access to treatment such as Trutusumab which will prolong life if treatment is completed and minimise the recurrence of the disease women.
End
South African National Department of Health
Health Minister Dr Aaron Motsoaledi has blamed manufacturers for shortages of medicines including HIV and tuberculosis drugs, but a civil society coalition has alleged 80%of stock outs are due to poor management.
Community members have also complained about medicine stock outs.
In the Stop the Stock Outs Project’s latest survey, more than 40 percent of health facilities reported having experienced a HIV, TB drug stock out: Joe Gqabi and Alfred Nzo districts, Eastern Cape; Bojanala District, North West; Nkangala and Gert Sibande districts, Mpumalanga; and Lejweleputswa and Fezile Dabi districts, Free State.
According to Motsoaledi, recent reports by Times Live and eNCA regarding alleged widespread drug shortages promoted the minister’s early return last week from the World Health Organisation’s on-going, annual World Health Assembly in Geneva.
At a Pretoria press conference yesterday, Motsoaledi widespread shortages of drugs including the country’s three-in-one antiretroviral (ARVs) fixed-dose combination (FDC).
“The FDC is our flagship programme and we do everything in our power to protect it,” Motsoaledi said in a statement. “To make sure that there are not problems in this very important programme, we even implemented the practice of a national buffer stock whereby 10 percent of all the FDCs we provide are strategically stockpiled with a service provider in a warehouse.”
Motsoaledi also added that the county source the combination ARV from three different suppliers to guard against supplier problems affecting supply.
“At no stage did we have a shortage of FDC in the country,” he added.
As of September 2015, about 119,000 patients had been started on the FDC.
One in five facilities have experienced stock outs
The department recently released a list of at least 40 medications -(comment by Vicki Pinkney-Atkinson many of these critical for the treatment of NCDs, morphine and mental health medication)– that were running short at provincial depots nationwide. The department attributed the bulk of shortages to supplier constrained and shortages of the pharmaceutical ingredients used to make the drugs.
Stock outs of medicines are indicative of a bigger problem related to the management and accountability in a health system”
Comprised of civil groups including Medicines Sans Frontières, the Treatment Action Campaign and the Southern African HIV Clinicians Society, the Stop Stock Outs Project (SSP) collects stock out reports from health workers and clinics nationwide.
The group recently surveyed more than 2,500 of the country’s 3,732 health facilities. According to the research to be presented at the upcoming SA AIDS Conference, one in five facilities reported experiencing an ARV or TB medication stock out.
According to a SSP statement released yesterday, management or logistical challenges between medicine depots and clinics caused 80% of stock outs.
However, the group noted that patients were turned away without any medication in only 20 percent of cases.
“Supply of medicine to clinics and hospitals is the basic pillar to any public health system and stock outs of medicines are indicative of a bigger problem related to the management and accountability in a health system,” said SSP’s Dr Karl Le Roux in the statement.
The findings show an improvement over the group’s previous survey in which about one in four facilities reported stock outs.
However, >40% of health facilities in seven districts reported at least one HIV and TB drug stock outs. These districts include the Eastern Cape’s Joe Gqabi and Alfred Nzo as well as the Free State’s Lejweleputswa and Fezile Dabi districts. – Health-e News
Do you know of a stock out?
Email the Department of Health
or Stop Stock Outs sms or What’s App 084.855.7867 or email
© 2015 Health-e. All Rights Reserved.
After months of painstaking work, the result of the South African Civil Society NCDs Benchmarking exercise is out for your comment. While every effort has been taken to ensure that this draft is correct and supported by documentary evidence and other input, we apologise in advance for any errors.
We sincerely ask for your input to ensure it is as accurate as possible. Written input using the item number concerned is most welcome.
Click here to download The attached draft copy of the SA Civil Society NCDs Benchmarking Exercise for your constructive comment and correction by 11 November 2014.
This NCD Benchmarking Exercise aims to assess the national capacity for responding to NCDs – from a civil society perspective.
It is framed to complement national reporting processes on NCDs, as well as WHO monitoring on NCDs.
It includes elements of the NCD national response/capacity that are not reflected in official government/WHO reporting, such as elements that relate to civil society organization engagement and capacity.
The benchmarking tool was developed in consultation with an expert working group of the NCD Alliance.
It is piloted as part of the NCD Alliance programme “Strengthening Health Systems, Supporting NCD Action” in Brazil, the Caribbean Community and South Africa.
The programme is funded by a generous grant from Medtronic Philanthropy.
Please return comments to Vicki Pinkney-Atkinson
After months of painstaking work, the result of the South African Civil Society NCDs Benchmarking exercise is out for your comment. While every effort has been taken to ensure that this draft is correct and supported by documentary evidence and other input, we apologise in advance for any errors.
We sincerely ask for your input to ensure it is as accurate as possible. Written input using the item number concerned is most welcome.
Click here to download The attached draft copy of the SA Civil Society NCDs Benchmarking Exercise for your constructive comment and correction by 11 November 2014.
This NCD Benchmarking Exercise aims to assess the national capacity for responding to NCDs – from a civil society perspective.
It is framed to complement national reporting processes on NCDs, as well as WHO monitoring on NCDs.
It includes elements of the NCD national response/capacity that are not reflected in official government/WHO reporting, such as elements that relate to civil society organization engagement and capacity.
The benchmarking tool was developed in consultation with an expert working group of the NCD Alliance.
It is piloted as part of the NCD Alliance programme “Strengthening Health Systems, Supporting NCD Action” in Brazil, the Caribbean Community and South Africa.
The programme is funded by a generous grant from Medtronic Philanthropy.
Please return comments to Vicki Pinkney-Atkinson
